---
title: OCT Clinical vs ProRelix Research
slug_a: oct-clinicaltrials
slug_b: prorelixresearch
site: cro
review_signal_gate: closed
canonical_path: /compare/oct-clinicaltrials/prorelixresearch
---

# OCT Clinical vs ProRelix Research

Side-by-side profile data from each company listing on this directory.

## OCT Clinical

- Profile: [/companies/oct-clinicaltrials](/companies/oct-clinicaltrials)

OCT Clinical — OCT Clinical runs Phase I–IV and BE trials across Central and Eastern Europe, including first-in-human and post-authorization studies. Its network of principal investigators covers more than 1,600 medical sites.

Services: 10. Modalities: 0. Indications: 5. Locations: 20. Certifications: 0. The strongest documented coverage currently appears in locations (20).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Psychiatry
- Infectious Disease
- Gastroenterology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## ProRelix Research

- Profile: [/companies/prorelixresearch](/companies/prorelixresearch)

ProRelix Research — ProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia.

Services: 9. Modalities: 0. Indications: 0. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)